KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $952,383 | -13.2% | 29,874 | +9.4% | 0.00% | 0.0% |
| Q2 2023 | $1,097,195 | -0.4% | 27,307 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $1,101,404 | +14.1% | 25,794 | +28.3% | 0.00% | 0.0% |
| Q4 2022 | $965,267 | +276.7% | 20,104 | +195.2% | 0.00% | – |
| Q3 2022 | $256,230 | -28.2% | 6,811 | +3.7% | 0.00% | – |
| Q1 2022 | $357,005 | -25.6% | 6,565 | -20.0% | 0.00% | – |
| Q4 2021 | $480,000 | +42.4% | 8,209 | -3.5% | 0.00% | – |
| Q3 2021 | $337,000 | -12.0% | 8,508 | -5.6% | 0.00% | – |
| Q2 2021 | $383,000 | -17.8% | 9,012 | +18.9% | 0.00% | – |
| Q1 2021 | $466,000 | -14.5% | 7,579 | -2.0% | 0.00% | -100.0% |
| Q4 2020 | $545,000 | – | 7,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |